RANKL–OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy
- 12 August 2014
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 57 (11) , 2251-2260
Abstract
Type 2 diabetes is associated with increased cardiovascular morbidity and mortality and early vascular ageing. This takes the form of atherosclerosis, with progressive vascular calcification being a major complication in the pathogenesis of this disease. Current research and drug targets in diabetes have hitherto focused on atherosclerosis, but vascular calcification is now recognised as an independent predictor of cardiovascular morbidity and mortality. An emerging regulatory pathway for vascular calcification in diabetes involves the receptor activator for nuclear factor κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG). Important novel biomarkers of calcification are related to levels of glycation and inflammation in diabetes. Several therapeutic strategies could have advantageous effects on the vasculature in patients with diabetes, including targeting the RANKL and receptor for AGE (RAGE) signalling pathways, since there has been little success—at least in macrovascular outcomes—with conventional glucose-lowering therapy. There is substantial and relevant clinical and basic science evidence to suggest that modulating RANKL–RANK–OPG signalling, RAGE signalling and the associated proinflammatory milieu alters the natural course of cardiovascular complications and outcomes in people with diabetes. However, further research is critically needed to understand the precise mechanisms underpinning these pathways, in order to translate the anti-calcification strategies into patient benefit.Keywords
This publication has 101 references indexed in Scilit:
- Genetic Pathways of Vascular CalcificationTrends in Cardiovascular Medicine, 2012
- NT5EMutations and Arterial CalcificationsNew England Journal of Medicine, 2011
- Elastin Degradation and Vascular Smooth Muscle Cell Phenotype Change Precede Cell Loss and Arterial Medial Calcification in a Uremic Mouse Model of Chronic Kidney DiseaseThe American Journal of Pathology, 2011
- Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetesClinical Science, 2010
- Regulatory mechanisms in vascular calcificationNature Reviews Cardiology, 2010
- Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease PredictionJAMA, 2010
- Streptozotocin, Type I Diabetes Severity and BoneBiological Procedures Online, 2009
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligandDiabetologia, 2008
- Contribution of VCAF‐positive cells to neovascularization and calcification in atherosclerotic plaque developmentThe Journal of Pathology, 2006